Skip to main content
HEALTH SOLUTIONS

Life sciences

Overview

Experts in healthcare access

The access challenges facing healthcare products are becoming more and more complex. With direct experience serving stakeholders across the U.S. healthcare system, we can help you understand the market, identify actionable insights, develop market-ready strategies, and execute to the top of your potential.

Our solutions are tailored to your needs, whether you’re focused on small molecule pharma, gene and cell therapies, rare disease, biosimilars, or medical devices.

Hear from
Milliman Life Sciences leaders

Watch our experts in conversation on key topics affecting the industry.

View the recordingsNavigation Arrow
Man preparing to use an auto injector syringe at a table.
Drug costs

GLP-1 medications

With benefits far beyond weight loss, patient uptake of GLP-1s is rising. Milliman is analyzing the impact across the healthcare ecosystem to help payers, life sciences companies, and other stakeholders adapt.

Read our researchNavigation Arrow

Read our latest thought leadership

office workers and city skyline
White paper

Beyond the federal account: How geographic and facility-level views of the Military Health System can unlock insights for life sciences companies

Life sciences companies that can analyze the Military Health System down to the facility level—rather than as one federal account—stand to gain an edge.

Read the articleNavigation Arrow
Interactive report

How can geographic data inform healthcare strategy?

We take a closer look at the variation in healthcare patterns across regions—and what’s driving the differences—to help better prepare stakeholders.

Read the articleNavigation Arrow
pharmacists with pill bottles
White paper

Direct-to-patient prescription drugs: A framework to help pharmaceutical manufacturers evaluate their strategy

We outline considerations on evaluating medication suitability for manufacturers looking to expand their presence in the direct-to-patient market.

Read the articleNavigation Arrow
Special series

Life sciences by the numbers

Quick takes on key topics affecting pharmaceutical companies and other healthcare stakeholders.

Read the articlesNavigation Arrow

Learn more about our comprehensive suite of services

Market access strategy

Market access strategy

Develop strategies and tactics that drive product access.

With expertise in payer, pharmacy benefit managers (PBM), and integrated delivery networks (IDNs), we can help you identify access opportunities specific to your products. We speak your customers’ language, informed by our industry knowledge and supported by unbeatable pharmacy and medical data.

Learn more

Health economics and outcomes research

Health economics and outcomes research

Create the studies and evidence that support your value proposition.

Our cross-functional team of experts can help you advance your health economic or medical- affairs strategy, regardless of where your product is in its life cycle.

Learn more

Policy research and analysis

Policy research and analysis

Navigate the ever-changing policy landscape.

From proposed rule to policy, our team of experts can help you understand the spirit, implementation, and potential impact of health policy. From your perspective or your customers’, we analyze relevant scenarios, driving toward actionable strategies and tactical response.

Learn more

Sticky note brainstorming planning board.

Payer and access agency support

Creative experts who know access.

Our full-service agency uses a data-driven approach to identify opportunities and develop the strategies and tactics to unlock performance. Our clinicians, strategists, and creatives have extensive experience in launch-readiness planning and optimization for in-line products.

Learn more

Pharmacists at work.

Specialty pharmacy and hub support

Thoughtful design for the patient experience.

Getting your therapies to patients requires successfully engaging a complex and highly regulated landscape. Whether you’re looking to establish a new distribution strategy, access mail-order distributors, work with a specialty pharmacy network, or pursue other pharma supply chain strategies, we can help.

Learn more

Business development

Business development

Better assumptions to size the opportunity.

Our team of experts can help teams to size an opportunity and estimate how the U.S. healthcare system may impact an asset’s potential future revenue.

Learn more
Milliman Data

Milliman Consolidated Health Cost Guidelines™ databases

Claim line detail for medical and prescription drug claims and enrollment.

Learn more about our data assets
  Heading Content Lines of business Estimated lives represented
Milliman Proprietary Data CHSD+ The Consolidated Health Cost Guidelines Databases (CHSD) includes claim line detail for medical and prescription drug claims and enrollment Commercial
Medicare Advantage
Managed Medicaid 		Almost 90 million
Milliman Proprietary Data Medicare PDCD The Medicare Prescription Drug Consolidated Database includes drug claims and enrollment Medicare Part D Over 6 million
Industry Data CMS 100% Research Identifiable Files Claim line detail for medical and prescription drug claims and enrollment Fee-for-service (FFS) Medicare
Medicare Advantage
Medicaid 		All beneficiaries
Industry Data CMS 5% Sample / 100% Data Sets Claim line detail for medical claims and enrollment Fee-for-Service (FFS) Medicare All beneficiaries
Industry Data MarketScan Claim line detail for medical and prescription drug claims and enrollment Commercial 35 million
Milliman Proprietary Data State Discharge Inpatient discharges, no membership All 100% of Admissions in Available States

We’re here to help

Ask the tough questions. We’re ready for them.